Multidrug Resistance and ABC Transporters

Abcam, Inc.
Last Modified: June 1, 2008

Conference Dates: November 5, 2008
Conference Location: Baltimore, Maryland

Sponsoring Group: Abcam, Inc.

Conference Web Page URL:

Topics Covered: The meeting will cover multidrug resistance in cancer and ABC transporters - basic, clinical, regulation and drug-drug interaction aspects.

Conference Objectives: Multidrug resistance in cancer and ABC transporters

Conference Agenda: Confirmed speakers: [Keynote] Dr Michael M. Gottesman (National Cancer Institute, NIH), Current status of multidrug resistance and ABC transporters - Dr Robert B. Innis (Molecular Imaging Branch, NIMH), Positron emission tomographic imaging of drug efflux transporters - Dr David S. Miller (NIEHS, NIH), Regulation of P-glycoprotein and other ABC drug transporters at the blood-brain barrier - Dr Gilbert J. Burckart (U.S. Food and Drug Administration), Drug-drug interactions and regulatory implications for membrane transporter substrates in drug development - Dr Maria R. Baer (University of Maryland Greenebaum Cancer Center), Clinical and therapeutic implications of multidrug resistance-associated ABC drug transporters - Dr Suresh V. Ambudkar (National Cancer Institute), Mechanism of action of multidrug resistance-linked ABC drug transporters

Registration Information: Oral abstract deadline: August 5, 2008 Poster abstract deadline: October 5, 2008 Early bird discount deadline: September 5, 2008

Conference Fees: $125.00

Continuing Education: No


7 Tips for Giving Smart on #givingtuesday
by Christina Bach, MSW, LCSW, OSW-C
November 25, 2015

Related News

CERT Expression of Prognostic Utility in Breast Cancer

Oct 4, 2011

Depletion of ceramide transporter increases autophagy and death of multinucleated cells

Brain Tumor Stem Cell-Like Cells Highly Tumorigenic

Nov 26, 2015

Temozolomide treatment increases stem cell-like population

2002 to 2008 Saw Increase in Partial Nephrectomy Use

Feb 20, 2012

For patients with renal masses, use of partial nephrectomy increased from 15.3 to 24.7 percent